SCAMP1

SCAMP1 is an integral membrane protein of the secretory and endocytic pathways that couples membrane trafficking events to clathrin-mediated coat assembly and to the dynamics of exocytic fusion pores (PMID:10777571, PMID:21272170). Its N-terminal NPF repeats bind the EH domain proteins intersectin 1 and gamma-synergin, linking SCAMP1 to clathrin coat recruitment at the plasma membrane and the trans-Golgi network; an NPF-deleted dominant-negative form blocks transferrin endocytosis (PMID:10777571). During regulated exocytosis, SCAMP1 is required not for fusion itself but for stabilizing and resolving the fusion pore: SCAMP1-null mast cells display reduced net capacitance gain and a higher fraction of reversible kiss-and-run events (PMID:10551807), and SCAMP1-deficient PC12 cells fail to properly dilate and close dense-core-vesicle fusion pores, accumulating fusion figures and shifting toward compound exocytosis (PMID:21272170). SCAMP1 is tyrosine-phosphorylated upon EGF stimulation and associates with the activated EGF receptor (PMID:9658162). Beyond trafficking, SCAMP1 acts as a host restriction factor against hepatitis B virus by suppressing the EnhI/XP, SP1, and SP2 promoters to lower viral X and S transcripts (PMID:35216324), and it modulates tumor cell behavior, cooperating with MTSS1 to elevate RAC1-GTP and restrain breast cancer invasion (PMID:29497041). The molecular basis connecting SCAMP1's trafficking role to these signaling and transcriptional phenotypes has not been resolved in the available corpus.

1. 1998 Medium

   Established that SCAMP1 is a downstream target of growth factor receptor signaling, placing a vesicle membrane protein within the EGFR response.

   Evidence Co-IP with EGFR and phosphotyrosine detection in EGF-stimulated fibroblasts overexpressing EGFR; in vitro EGFR kinase assay on SCAMP3

   PMID:9658162

   Open questions at the time

   • Direct in vitro phosphorylation of SCAMP1 (as opposed to SCAMP3) by EGFR was not demonstrated
   • The functional consequence of SCAMP1 tyrosine phosphorylation is unknown
   • Phosphosite identity on SCAMP1 not mapped
2. 1999 High

   Resolved whether SCAMP1 is essential for exocytosis itself versus pore stability, showing it controls stable fusion pore formation rather than triggering fusion.

   Evidence SCAMP1 knockout mouse with whole-cell capacitance measurements in GTPγS-stimulated mast cells

   PMID:10551807

   Open questions at the time

   • Molecular mechanism by which SCAMP1 stabilizes the fusion pore not defined
   • Viability of knockout indicates functional redundancy that is uncharacterized
3. 2000 High

   Defined the molecular interactions underlying SCAMP1's trafficking role, linking its NPF repeats to EH-domain endocytic adaptors and to clathrin coat assembly.

   Evidence Co-IP/pulldown of NPF repeats with intersectin 1 and gamma-synergin; dominant-negative ΔNPF inhibition of transferrin endocytosis

   PMID:10777571

   Open questions at the time

   • Whether SCAMP1 directly nucleates clathrin coats or acts as a scaffold not distinguished
   • Relative contribution at plasma membrane versus TGN not quantified
4. 2011 High

   Extended the pore-stability role to neuroendocrine secretion and into exo-endocytic coupling, showing SCAMP1 controls both fusion pore dilation and closure.

   Evidence siRNA knockdown in PC12 cells with real-time imaging of dense-core-vesicle fusion pore dynamics and rescue by re-expression

   PMID:21272170

   Open questions at the time

   • Direct biophysical mechanism of pore dilation/closure control not established
   • Link to the NPF/EH-domain endocytic machinery not tested in this context
5. 2013 Low

   First implicated SCAMP1 in cancer cell motility, associating its loss with reduced migration, invasion, and VEGF secretion.

   Evidence siRNA knockdown in pancreatic and gallbladder cancer cell lines with migration/invasion assays and VEGF ELISA

   PMID:23653380

   Open questions at the time

   • Single-method knockdown without rescue or mechanistic pathway placement
   • Whether the VEGF effect is direct or secondary is unknown
6. 2018 Medium

   Provided a trafficking-based mechanism for SCAMP1 in tumor suppression, linking it to MTSS1 transport and RAC1 regulation.

   Evidence Interaction screening with RAC1-GTP pulldown, invasion and cell-cell adhesion assays in HER2+/ER-/PR- breast cancer lines

   PMID:29497041

   Open questions at the time

   • How SCAMP1 promotes MTSS1 trafficking mechanistically is indirect/unresolved
   • Direct physical interaction between SCAMP1 and MTSS1 not firmly established
   • Generalizability beyond the tested breast cancer subtype unknown
7. 2022 Medium

   Identified an antiviral function for SCAMP1 as an HBV restriction factor acting at the level of viral promoter activity.

   Evidence Overexpression and siRNA knockdown in hepatocytes with RT-qPCR, ELISA, and EnhI/XP, SP1, SP2 promoter reporter assays

   PMID:35216324

   Open questions at the time

   • Mechanism by which a membrane trafficking protein suppresses viral promoters is unexplained
   • Single lab, single study without independent confirmation
8. 2024 Low

   Associated SCAMP1 with proliferative oncogenic signaling in gastric cancer, contrasting with its tumor-suppressive role elsewhere.

   Evidence siRNA/shRNA knockdown, xenograft model, RNA-seq, and immunoblotting for pAkt/pMAPK/pStat

   PMID:39308691

   Open questions at the time

   • No direct mechanistic link between SCAMP1 and RTK/Akt signaling established
   • Apparent opposite role versus breast cancer not reconciled

• How SCAMP1's defined trafficking activity (NPF/EH-domain coat assembly and fusion pore control) mechanistically gives rise to its reported roles in viral promoter suppression and divergent cancer signaling outcomes remains unresolved.
• No mechanism connecting membrane trafficking function to transcriptional/signaling phenotypes
• Opposing tumor-suppressive and tumor-promoting reports not reconciled
• No structural model of SCAMP1 in coat or pore contexts